Cargando…
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
Vectored immunoprophylaxis was first developed as a means of establishing engineered immunity to HIV using an adenoassociated viral vector expressing a broadly neutralizing antibody. We applied this concept to establish long-term prophylaxis against severe acute respiratory syndrome coronavirus 2 (S...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
National Academy of Sciences
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266030/ https://www.ncbi.nlm.nih.gov/pubmed/37252952 http://dx.doi.org/10.1073/pnas.2303509120 |